/_media/adv/web/images/2011/20111124_Arthrex_TB-378x82.jpg

Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2012/20120126_APIC_LB-154x100.jpg
/_media/adv/web/images/2011/20110502_Provista_LB-154x100.gif
/_media/adv/web/images/2011/20111226_Soma_LB-154x100.gif
/_media/adv/web/images/2011/20111202_Arthrex_LB-154x100.jpg
Outpatient Surgery E-Weekly

Contact Congress Over Drug Shortage Issues

A Kentucky congressman is urging surgical facilities to contact their members of Congress and request that they sign his letter demanding changes to...

N.J. Posts ASC Inspection Reports Online

State and federal inspection reports of New Jersey's ASCs are now available online, giving patients an opportunity to make more informed choices abo...

Are Opioids Necessary?

While it's not always practical, or even possible, to eliminate opioids from your post-op pain management regiment, reducing their use in favor of n...

Archive >  Surgical Drugs 2005

Sizing Up Non-opioid Analgesics

From ibuprofen to the controversial COX-2s, here's what you need to know.

Julie Golembiewski, PharmD

Vioxx is out, pulled off the shelves by Merck after a clinical trial revealed that the COX-2 inhibitor increased the risk of heart attacks and strokes in users. Gone, too, is Bextra. Pfizer voluntarily withdrew the drug from the market when further review of data revealed that it, too, can increase the risk of heart attack and stroke. Which leaves Celebrex - slower-acting than Vioxx and Bextra and, for now, with fewer known side effects - as the COX-2 inhibitor used by surgical facilities to tame pain.

Sign in to continue reading.
Email Address:
Password:
Categories: Anesthesia, Business Management, Pain Management, Supplies/Implants
Keywords:
Aspirin; Bextra; Bextra. One-time; Bextra. Pfizer; Celebrex; Choices; Diclofenace; Duration; Effect; Etodolac; GI; Glance Agent Peak Effect; Ibuprofen; Meclofenamate; Mefenamic; Merck; NSAID; NSAIDS; NSAIDs; NSAIDs. Oxicam; Nabumetone; One-time; Pfizer; Phenylbutazone; Piroxicam; Salsalate; Sulindac; Targeting; Tometin; Unlike; Vioxx; abdominal; ability; absorbs; accomplish; account; achieved; acid; act; action; active; acts; acute; additions; administration; adverse; alike; analgesic; anti-inflammatory; aplastic; aspirin; assist; association; attack; based; begin; benefits; best-studied; big;... show all keywords
Aspirin; Bextra; Bextra. One-time; Bextra. Pfizer; Celebrex; Choices; Diclofenace; Duration; Effect; Etodolac; GI; Glance Agent Peak Effect; Ibuprofen; Meclofenamate; Mefenamic; Merck; NSAID; NSAIDS; NSAIDs; NSAIDs. Oxicam; Nabumetone; One-time; Pfizer; Phenylbutazone; Piroxicam; Salsalate; Sulindac; Targeting; Tometin; Unlike; Vioxx; abdominal; ability; absorbs; accomplish; account; achieved; acid; act; action; active; acts; acute; additions; administration; adverse; alike; analgesic; anti-inflammatory; aplastic; aspirin; assist; association; attack; based; begin; benefits; best-studied; big; bleeding; blood; cardiac; caused; changed; chemical; choice; choline; choose; clinical; common; commonly; compared; considered; consumers; continues; control; correctly; cost; cramping; data; deciding; depend; depending; differ; discussed; disruption; dose; doses; drowsiness; drug; drugs; effect; effective; effects; elimination; equally; exacerbation; extraordinarily; facilities; factor; fewer; first-line; first-pass; fluctuates; gastrointestinal; half-hour; half-life; hand; healthcare; heart; high; hospitals; hour; hours; hypertension; impair; important; include; increase; inflammation; inhibitor; inhibitors; injectable; invasive; ketorolac; labels; lasts; leaves; levels; long; long-term; long-time; low; magnesium; major; management; market; matter; medications; minimally; moderately; morphine; nature; non-acidic; non-steroidal; normal; occur; oft-used; once-daily; one-and-a-half; one-half; opioids; options; oral; outpatient; over-the-counter; pain; patient; patients; peak; perioperative; platelets; pose; post-op; potential; preference; prescription; pretty; primarily; primary; problematic; problems; properties; provider; pulled; quickly; rapidly; reach; reason; recent; recommended; reduction; relieve; remain; renal; revealed; review; revised; risk; section; select; selectivity; setting; severe; shelves; short-term; shown; side; similar; skin; slower-acting; sodium; specific; starts; stomach; strokes; structure; structures; studies; surgery; surgical; system; tame; tissue; tolerance; tolerate; toxicity; treating; trial; trisalicylate; two-and-a-half; type; underlying; unlike; voluntarily; ways; weak; withdrew; work

© Copyright Herrin Publishing Partners LP 2011. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.

PRODUCT & SERVICE RESOURCES
Did You See This?
A showcase of products and services geared to make your facility better.

Architects' Showcase
Is a beautiful, efficient new facility in your future?
/_media/adv/web/images/2011/20111111_CareFusion_AR-300x250.jpg
Other Articles That May Interest You
Are You Prepared for Malignant Hyperthermia?
Experts urge evaluation of resources, coordination of transfer strategies.
Court: Stryker Still on the Hook for Pain Pump Liability
Denies manufacturer's request to dismiss injured patient's lawsuit.
ASC Seeks $300,000 From Surgeon for Violating "Exclusive-Use" Agreement
Lawsuit claims neurosurgeon failed to reimburse facility for leasing surgical center space and billing services.